$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
In 1946, Lederberg and Tatum1 described a sexual process in Escherichia coli K-12 that is now known as conjugation. Bacterial conjugation is the process by which a bacterial cell (the donor) transfers unidirectionally genetic material to another cell (the recipient) by direct cell-to-cell contact. Conjugation is broadly distributed in bacteria2,3, although the fraction of donor cells expressing the conjugation machinery is typically very small4.
Plasmids are autonomously-replicating extrachromosomal DNA elements. In addition to genes involved in plasmid replication and maintenance, plasmids frequently carry a cargo of genes involved in adaptation to environmental challenges, such as heavy metals or exposure to antibiotics5. Conjugative plasmids are a class of plasmids with a set of specialized genes that allow their transfer to recipient cells and support their persistence following the transfer6. Conjugative plasmids vary in size from 21.8 kb to 1.35 Mb in bacteria in the phylum Pseudomonadota (synonymous with Proteobacteria), with the median around 100 kb5,7. They also generally have a low copy number, possibly to keep the metabolic burden on the host low8,9.
The typical conjugative apparatus consists of four components: an origin of transfer (oriT), a relaxase, a type IV coupling protein, and a type IV secretion system (a tube-like structure called pilus that allows donors to contact recipients)6. Only a very small fraction of cells carrying conjugative plasmids express the conjugation machinery4, but if the plasmids provide a fitness advantage, the transconjugants can rapidly expand in the population. Between 35% and over 80% of E. coli isolates collected from different habitats have conjugative plasmids with genes that confer resistance to at least one antibiotic10,11; therefore, horizontal gene transfer mediated by conjugative plasmids is a major mechanism driving the global spread of antibiotic resistance genes12.
Mating experiments conducted in laboratory culture have shown that the conjugation frequency is affected by multiple factors, including the nature of the recipient cells, growth phase, cell density, donor-to-recipient ratio, whether conjugation is conducted in liquid or solid media, carbon, oxygen, bile salts, metal concentrations, presence of mammalian cells, temperature, pH, and mating time13,14,15.
This work describes protocols to detect the presence of conjugative plasmids in a given host strain, to quantify the conjugation rates in solid culture, and to double-check their transfer to recipient cells. These protocols can be used as a first step for the identification of natural conjugative plasmids suitable for research. They use a minimum number of simplified steps because they are designed to screen the presence of conjugative plasmids in bacteria obtained from multiple sources (environmental, commensal, and pathogenic) at scale (dozens to hundreds of donors).
In addition, tests to detect whether the mobilization of a given conjugative plasmid is independent of the antibiotic used for detection (i.e., the relevance of the antibiotic resistance gene under selection) and to compare the conjugation rates of two conjugative plasmids found in different environmental isolates are shown.
Based on the genetic composition of the relevant conjugative plasmids (plasmid replicon and antibiotic resistance gene makeup), each step of the protocol can be modified to study the impact of a variety of factors likely to affect the conjugation rate.
General experimental design:
The essential components needed to set up a mating experiment are donor cells, a recipient strain, and solid media to select donors (antibiotic A), recipients (antibiotic B), and transconjugants (antibiotic A and B). Transconjugants are recipient cells that stably maintain the conjugative plasmid of the donor.
Donor cells are resistant to an antibiotic (antibiotic A) and are susceptible to the marker or markers used to select recipient cells (antibiotic B). The genomic location of the antibiotic resistance gene (i.e., whether it is located in the chromosome or a plasmid of the donor cell) does not have to be known a priori, because mobilization of antibiotic resistance markers to the recipient (after a direct donor-recipient contact) implies that the donor-provided markers were in a plasmid.
A recipient strain (known to take conjugative plasmids) needs to have a stable selectable marker not present in the donor; this selectable marker is generally resistant to an antibiotic or biocide located in the chromosome. The selection of the recipient to be used in mating experiments is critical, because some E. coli strains vary in their ability to take conjugative plasmids16.
Once these components have been established, any colony that grows on media with both antibiotics (A and B) after a donor-recipient pair contact is a putative transconjugant (Figure 1). This is assuming that donors can grow in media with antibiotic A but cannot grow in media with antibiotic B, and that recipients are able to grow in media with antibiotic B, but not able to grow with antibiotic A. Transconjugation can be confirmed using two diagnostic tests. The first test consists of the detection (by polymerase chain reaction [PCR] amplification of genes, or other methods) of genes found in the conjugative plasmid in transconjugant colonies. The second test involves the use of differential colony color markers based on lactose metabolism. The differential colony color is revealed by the use of MacConkey agar; the lactose in the agar can be used as a fermentation source by lactose-fermenting (lac+) microorganisms. These microorganisms produce organic acids, particularly lactic acid, which lower the pH. Neutral red is a pH indicator included in the media that turns from off-white to bright red/pink as the pH drops below 6.817. Thus, E. coli lactose-positive strains produce larger pink colonies on MacConkey agar, whereas lactose-negative strains produce pale yellow and smaller colonies on MacConkey agar.

Figure 1: Experimental design used to detect the presence of conjugative plasmids in donor strains. In this example, the donor carries a conjugative plasmid with an antibiotic resistance gene that confers resistance to antibiotic A, but they are susceptible to antibiotic B. Conversely, the recipient has a chromosomal resistance determinant that confers protection from antibiotic B, but it is susceptible to antibiotic A. Transconjugants are resistant to both antibiotics (A and B), because they have the conjugative plasmid of the donor that confers resistance to antibiotic A and the chromosome of the recipient that confers protection from antibiotic B. Please click here to view a larger version of this figure.
The conjugation rate for a donor-recipient pair (under given experimental conditions) can be calculated by dividing the number of transconjugants by the number of donors or by the number of recipients; the first rate indicates the fraction of donor cells exhibiting functional expression of the conjugation machinery by the donor16,18, while the second rate indicates the ability of the recipient to take conjugative plasmids19,20. In this study, unless otherwise stated, the conjugation rate represents the fraction of recipient cells that become transconjugant (i.e., rate per recipient).
Here, two independent mating experiments are reported, involving one E. coli recipient and two E. coli donors. In addition, different antibiotics were used to select transconjugants for one of the donors to confirm that a single multidrug-resistant plasmid can be selected with any of the antibiotic resistance genes found in the conjugative plasmid.
The donor and recipient strains used in this work have been fully sequenced to understand all components of this experimental system; however, these protocols were designed to screen for the presence of conjugative plasmids in hosts of unknown sequence, and can be used in this experimental context as well; however, in this case, the relevant genes are sequenced first.
The donor and recipient strains used in the protocol are the following:
Donor 1. E. coli SW4955 was collected in a lake in Baton Rouge (LA, USA). It has a 134,797 bp conjugative plasmid (p134797) with IncFIC(FII) and IncFIB (AP001918) replicons. This conjugative plasmid has genes that confer resistance to third-generation cephalosporins (blaCTX-M-55), aminoglycosides (aac(3)-IIa and aadA1), phenicols (catA2), tetracyclines (tet(A)), trimethoprim (dfrA14), and sulphonamides (sul3). For a complete map of p134797, please see Figure 2A. E. coli SW4955 is lactose-positive, producing pink colonies on MacConkey agar.
Donor 2. E. coli SW7037 was collected in Lake Erie (Ottawa County, OH, USA). It carries a 101,718 bp conjugative plasmid (p101718) with an IncI1-I(Alpha) replicon. This conjugative plasmid has a gene that confers resistance to beta-lactams (blaCMY-2). For a complete map of p101718, please see Figure 2B. E. coli SW7037 is also lactose-positive, producing pink colonies on MacConkey agar.

Figure 2: Genetic map of the conjugative plasmids used in this study. (A) Plasmid p134797, the conjugative plasmid found in E. coli strain SW4955. (B) Plasmid p101718, the conjugative plasmid found in E. coli strain SW7037. Antibiotic resistance genes are highlighted in blue, and genes belonging to the conjugative apparatus are highlighted in red. Please click here to view a larger version of this figure.
Recipient. E. coli LMB100 is used as recipient. This is a plasmidless strain that is resistant to rifampin (100 mg/L) and to streptomycin (100 mg/L). Having resistance to two antibiotics reduces the possibility of resistance mutations arising in the donor that would interfere with the interpretation of results. In addition, E. coli LMB100 is lactose-negative, and can be distinguished from the two donor strains because it produces pale yellow and small colonies (as opposed to larger, pink colonies) on MacConkey agar.
When the donor is lactose-negative, we recommend to use of a lactose-positive recipient (e.g., E. coli J53). The LMB100 and J53 strains are available to other labs for use. Please send a request to Dr. Gerardo Cortés-Cortés along with an address and FedEx number.
The solid media needed to select and count donors, recipients, and transconjugants is MacConkey agar in Petri dishes 100 mm in diameter. The addition of the following antibiotics is needed: (i) Media A: carbenicillin (100 mg/L) to count donors and to ensure that recipients cannot grow with this antibiotic. (ii) Media B: rifampin (100 mg/L) + streptomycin (100 mg/L) to count recipients and to ensure that donors cannot grow in these two antibiotics. (iii) Media AB: carbenicillin (100 mg/L) + rifampin (100 mg/L) + streptomycin (100 mg/L) to obtain and count transconjugants. (iv) Media C: no antibiotics to streak all isolates studied.
The conjugation rates of conjugative plasmids from E. coli SW4955 and E. coli SW7037 to E. coli LMB100 are compared. In addition, in the case of the p134797 conjugative plasmid (SW4955 strain), the antibiotic carbenicillin (100 mg/L) is replaced by gentamicin (2 mg/L), chloramphenicol (25 mg/L), tetracycline (10 mg/L), trimethoprim (20 mg/L), or sulfamethoxazole (100 mg/L) in subsequent experiments to establish if the antibiotic resistance marker used for selection has any impact on the results.